跳至主要内容
临床试验/NCT05774548
NCT05774548招募中不适用

Epidemiological Impact and Cost-effectiveness of Long-acting Antiretrovirals for Pre-exposure Prophylaxis Among Key Populations in Thailand

Institute of HIV Research and Innovation Foundation, Thailand12 个研究点 分布在 1 个国家目标入组 10,720 人开始时间: 2022年3月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10,720
试验地点
12
主要终点
The epidemiological impact of long-acting antiretrovirals for HIV prevention among Thai MSM and TGW at risk of HIV infection

研究概览

简要总结

This study will have three components:

  1. Discrete choice experiments
  2. Analysis of routine service data
  3. Impact and cost-effectiveness analyses using results from 1 and 2

详细描述

Discrete choice experiments (DCE) will be part of a survey, assessing sociodemographic characteristics, risk behavior, PrEP related information. Two separate surveys and DCEs will be designed, one for MSM, and one for TGW. Information collected through DCEs will allow us to estimate user values in the absence of observations or readily available data, and use these preferences to inform mathematical modeling on the impact and cost-effectiveness of long-acting PrEP. DCEs will be designed as per best-practice guidance by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). To maximize statistical and response efficiency, the number of attributes selected for evaluation must be restricted, i.e. the most important attributes must be known prior to construction. Therefore, the DCE design and implementation of the survey will be conducted in different phases:

PHASE I - Identification of attributes In-depth interviews (IDIs) with up to 40 potential, current, previous PrEP users (20 MSM,20 TGW) will assess which attributes are most relevant among each population. Posters will be used to recruit participants for IDIs. Self-reported HIV-negative MSM, TGW who either report interest in PrEP use, current PrEP use, or past PrEP use, will be eligible to participate in the IDIs. IDIs will be conducted by the study staff by in-person or on-line interviews. Focus group discussion (FGD) will prepare to discuss the interested information from IDIs. Following IDIs, participants will be informed and invited to the focus group discussion. A FGD will recruit 6-10 IDI participants from each MSM, TGW group. A list of 10 random numbers will be generated using statistical software if more than 10 individuals show interest in participating in the FGD. If there are less than 6 accepted participants for the FGD, the backup list or a new participant will be invited. The study staff will perform FGD by in-person or on-line conference. Data obtained during this process will be used to create a final list of attributes for each population and their levels to include in the choice tasks, ensuring that the choices are plausible and exchangeable. The number of DCE choice sets will be about 6 per person.

PHASE II - Pilot testing of DCE (The result from Phase I will be used for finalize an initial draft in this part) Initial drafts of the choice tasks (one draft for MSM and one draft for TGW) will be administered to convenience samples of 30 MSM, 30 TGW (10% of phase III sample size), respectively, to obtain feedback about difficulty of tasks, plausibility of levels, length, wording and clarity using a survey form. Final DCEs for each population will be agreed upon by consensus, and incorporated in the surveys.

PHASE III - Survey implementation (The result from Phase II will be used for finalize a survey in this part).

Two final surveys will be launched:1 survey for MSM, 1 survey for TGW. Both surveys will collect data on:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Minimum age of 18 years
  • Individual assigned male at birth reporting sex with men in the past 12 months
  • Self-reported HIV-negative MSM and TGW who either report interest in PrEP use, current PrEP use, or past PrEP use
  • Permit audio recording during the interview and/or discussion.

排除标准

  • Not willing to participate in the study

研究组 & 干预措施

(PHASE I) Attributes identification

Experimental

To identify attributes of importance for our research question and assign possible levels to these attributes, a combination of literature review and qualitative approaches will be conducted

干预措施: In-depth interviews (IDI) (Other)

(PHASE I) Attributes identification

Experimental

To identify attributes of importance for our research question and assign possible levels to these attributes, a combination of literature review and qualitative approaches will be conducted

干预措施: Focus group discussion (FGD) (Other)

结局指标

主要结局

The epidemiological impact of long-acting antiretrovirals for HIV prevention among Thai MSM and TGW at risk of HIV infection

时间窗: 12 months

Epidemiological impact analyses will compare a current scenario in which PrEP is only available as an oral formulation to a scenario in which long-acting PrEP is also available.

The cost-effectiveness of long-acting antiretrovirals for HIV prevention among Thai MSM and TGW at risk of HIV infection

时间窗: 12 months

The cost-effectiveness analysis will be based on previous HIV transmission models published by the Erasmus Medical Centre

次要结局

  • Preferred PrEP modalities among Thai MSM and TGW, trade-off of different PrEP attributes(18 months)
  • Proportion of MSM and TGW indicating uptake of PrEP in hypothetic scenarios, impact of sociodemographic and behavioral characteristics on projected uptake(18 months)
  • Patterns of PrEP use(18 months)

研究者

发起方
Institute of HIV Research and Innovation Foundation, Thailand
申办方类型
Other
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验